Cresco Labs EBITDA 2020-2025 | CRLBF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Cresco Labs ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Cresco Labs ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$229.7B
Boston Scientific (BSX)	$152.7B
Stryker (SYK)	$148.7B
EssilorLuxottica (ESLOY)	$131.4B
Medtronic (MDT)	$115.3B
Lonza Group Ag (LZAGY)	$51.1B
Haleon (HLN)	$44.7B
ResMed (RMD)	$37.3B
Agilent Technologies (A)	$35B
GE HealthCare Technologies (GEHC)	$34.4B
Terumo (TRUMY)	$24.6B
Koninklijke Philips (PHG)	$23.1B
Insulet (PODD)	$20.4B
Zimmer Biomet Holdings (ZBH)	$18.6B
Baxter (BAX)	$14.7B
Smith & Nephew SNATS (SNN)	$13.3B
Demant (WILYY)	$9B
Sunny Optical Technology (SNPTF)	$8.6B
Bio-Rad Laboratories (BIO)	$7B
Lantheus Holdings (LNTH)	$5.6B
Perrigo (PRGO)	$3.8B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.4B
ICU Medical (ICUI)	$3.3B
QuidelOrtho (QDEL)	$2.1B
LeMaitre Vascular (LMAT)	$1.9B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.4B